±Ø¼Ò ÀúÃâ»ý üÁ߾ƿ¡¼ Liposomal Amphotericin B (AmBisome)À¸·Î Ä¡·áÇÑ Äµð´Ù ½É³»¸·¿° 1·Ê
Successful Treatment of Candida albicans Endocarditis with Liposomal Amphotericin B (AmBisome) in a Very Low Birth Weight Infant
¹ÚÈ«±Ô, ÀÌÇý¶õ, ±è¿µÈ£, ±è¹ÌÁø, Á¤Áö¾Æ, ¾ç½Â, ȲÀÏÅÂ, ¼º³²ÁÖ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÈ«±Ô ( Park Hong-Kyu )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÀÌÇý¶õ ( Lee Hae-Ran )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°ú
±è¿µÈ£ ( Kim Young-Ho )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±è¹ÌÁø ( Kim Me-Jin )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Á¤Áö¾Æ ( Jung Ji-Ah )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¾ç½Â ( Yang Seung )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ȲÀÏÅ ( Hwang Il-Tae )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¼º³²ÁÖ ( Sung Nam-Ju )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
KMID : 0438520060130010184
Abstract
Candida albicans endocarditis is an uncommon manifestation of systemic candidiasis in newborn infants who require intensive care and develops mostly in patients with congenital heart disease; open heart surgery is the majority of predisposing factor. Improvement of techniques managing premature infants leads to increased survival rates, which give much more chances to develop fungal infections and its complications. We report a case of very low birth weight infant who had candidemia and Candida endocarditis, who was successfully treated with AmBisome¢ç because of no response to conventional amphotericin B therapy. (J Korean Soc Neonatol 2006;13:184-188)
Å°¿öµå
Neonate;Candida albicans;Endocarditis;Liposomal Amphotericin B
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸